|
|
|
|
|||||
|
|
|
Here are three stocks with buy rank and strong momentum characteristics for investors to consider today, January 6:
Rigel Pharmaceuticals, Inc. RIGL: This biotechnology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 19.1% over the last 60 days.
Rigel Pharmaceuticals, Inc. price-consensus-chart | Rigel Pharmaceuticals, Inc. Quote
Rigel’s shares gained 39.6% over the last three months compared with the S&P 500’s advance of 2.7%. The company possesses a Momentum Score of A.
Rigel Pharmaceuticals, Inc. price | Rigel Pharmaceuticals, Inc. Quote
Canadian Imperial Bank of Commerce CM: This diversified financial institution has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 5.3% over the last 60 days.
Canadian Imperial Bank of Commerce price-consensus-chart | Canadian Imperial Bank of Commerce Quote
Canadian Imperial’s shares gained 13.7% over the past month compared with the S&P 500’s advance of 2.7%. The company possesses a Momentum Score of A.
Canadian Imperial Bank of Commerce price | Canadian Imperial Bank of Commerce Quote
NeuroOne Medical Technologies Corporation NMTC: This medical technology company has a Zacks Rank #1 and witnessed the Zacks Consensus Estimate for its current year earnings increasing 6.7% over the last 60 days.
NeuroOne Medical Technologies Corporation price-consensus-chart | NeuroOne Medical Technologies Corporation Quote
NeuroOne’s shares gained 16.1% over the last six months compared with the S&P 500’s advance of 10.7%. The company possesses a Momentum Score of A.
NeuroOne Medical Technologies Corporation price | NeuroOne Medical Technologies Corporation Quote
See the full list of top ranked stocks here
Learn more about the Momentum score and how it is calculated here.
Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report
This article originally published on Zacks Investment Research (zacks.com).
| 5 hours | |
| 9 hours | |
| 10 hours | |
| Jan-06 | |
| Jan-06 | |
| Dec-23 | |
| Dec-23 | |
| Dec-22 | |
| Dec-22 | |
| Dec-18 | |
| Dec-17 | |
| Dec-17 | |
| Dec-16 | |
| Dec-11 | |
| Dec-09 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite